BALF C-reactive protein shows promise, limits in canine pneumonia
Bottom line
Dogs with suspected bacterial bronchopneumonia may eventually have another data point to work with during bronchoalveolar lavage, but early evidence suggests bronchoalveolar lavage fluid C-reactive protein, or BALF-CRP, is better at ruling in disease than ruling it out. In a multicenter prospective study presented at the 2024 ECVIM-CA Congress, investigators evaluated 80 BALF samples collected from dogs between 2022 and 2024 and found that BALF-CRP above 5 mg/L had 30% sensitivity and 80% specificity for bacterial bronchopneumonia; at a cutoff above 11 mg/L, specificity rose to 94%, while sensitivity dropped to 20%. When BALF-CRP above 11 mg/L was paired with plasma CRP of at least 50 mg/L, specificity reached 100%, though sensitivity remained low at 18%. (academic.oup.com)
Why it matters: Diagnosis of canine bacterial bronchopneumonia still leans heavily on BALF cytology and bacterial culture, both of which have practical limitations, including turnaround time, contamination risk, and imperfect correlation with antimicrobial need. Prior canine studies have shown serum CRP can help distinguish bacterial pneumonia from other respiratory diseases, with bacterial pneumonia cases showing markedly higher serum CRP concentrations than dogs with nonbacterial respiratory conditions. This new BALF-focused work suggests local CRP measurement could become a useful adjunct when positive, especially while clinicians are waiting for cytology and culture, but its low sensitivity means it can't replace current diagnostics or justify withholding treatment when suspicion is high. (pubmed.ncbi.nlm.nih.gov)
What to watch: Watch for the full peer-reviewed Journal of Veterinary Diagnostic Investigation paper, which should clarify assay performance, case definitions, and whether BALF-CRP can be integrated into antimicrobial decision-making algorithms. (academic.oup.com)
A new study suggests C-reactive protein can be measured directly in canine bronchoalveolar lavage fluid, but the marker's clinical value appears to be narrow: potentially useful for supporting a diagnosis of bacterial bronchopneumonia when elevated, yet too insensitive to stand alone. In a multicenter prospective dataset presented at the 2024 ECVIM-CA Congress, BALF-CRP above 5 mg/L identified bacterial bronchopneumonia with 30% sensitivity and 80% specificity, while a higher threshold above 11 mg/L pushed specificity to 94% but reduced sensitivity to 20%. (academic.oup.com)
That matters because canine bacterial bronchopneumonia can be difficult to diagnose cleanly in practice. Lower airway sampling remains central, but BALF cytology doesn't always reveal intracellular bacteria, cultures can be delayed or confounded by contamination, and positive culture results don't always map neatly to antimicrobial need. A separate study on dogs with lower respiratory tract signs underscored that challenge, while also noting that serum CRP above 55 mg/L is strongly suggestive of bacterial bronchopneumonia and concentrations below 20 mg/L strongly argue against infection. (pmc.ncbi.nlm.nih.gov)
The BALF-CRP work builds on that earlier serum CRP literature rather than replacing it. In a 2013 prospective study, dogs with bacterial pneumonia had a median serum CRP of 121 mg/L, significantly higher than dogs with bacterial tracheobronchitis, chronic bronchitis, eosinophilic bronchopneumopathy, idiopathic pulmonary fibrosis, cardiogenic pulmonary edema, and healthy controls. Later work also showed CRP behaves differently across respiratory syndromes: in dogs with Bordetella bronchiseptica infection, median CRP was much lower than in dogs with aspiration bronchopneumonia, reinforcing that CRP's diagnostic usefulness depends on the underlying disease pattern. (pubmed.ncbi.nlm.nih.gov)
According to the congress abstract, investigators collected 80 BALF samples from dogs between 2022 and 2024, then classified 30 dogs as having bacterial bronchopneumonia and 50 as non-bacterial cases based on review by three board-certified internists. BALF-CRP was measured with a Thermo Fisher Konelab analyzer with a detection limit of 5 mg/L. At the more clinically selective threshold above 11 mg/L, the test's positive predictive value was 67% and negative predictive value was 66%. Combining BALF-CRP above 11 mg/L with plasma CRP at or above 50 mg/L produced 100% specificity and 100% positive predictive value in this cohort, but only 18% sensitivity, meaning many true cases would still be missed. (academic.oup.com)
The clearest expert signal so far comes from the investigators' own interpretation in the congress report: BALF-CRP appears "specific but insensitive" and may help support antibiotic administration while clinicians await other results, particularly when plasma CRP is also elevated. That's a measured conclusion, and the low sensitivity helps explain why. A positive result may strengthen confidence in a bacterial process, but a negative result doesn't do much to lower suspicion in a coughing, dyspneic dog with compatible imaging and cytology. (academic.oup.com)
Why it matters: For veterinary professionals, this is less a breakthrough diagnostic than a possible triage aid within a broader respiratory workup. In referral settings already performing bronchoscopy and BAL, BALF-CRP could eventually serve as one more piece of evidence when deciding whether empiric antimicrobials are justified before culture returns. But the current data don't support using the marker as a screening tool, nor do they suggest it should displace cytology, culture, imaging, or systemic inflammatory markers. The antimicrobial stewardship angle is still important: if future studies validate a highly specific combined BALF-CRP and plasma CRP approach, clinicians may gain a more defensible way to identify the subset of dogs in which immediate antibacterial treatment is most warranted. (pmc.ncbi.nlm.nih.gov)
There's also a practical caveat. Because BALF collection already requires an invasive procedure, the marker's main value would be in improving interpretation of samples already being obtained, not in creating a simpler frontline test for general practice. That distinguishes it from serum CRP, which is easier to collect and already has a stronger evidence base in canine respiratory disease. (pubmed.ncbi.nlm.nih.gov)
What to watch: The next step is the full Journal of Veterinary Diagnostic Investigation publication tied to this research topic, which should provide the complete methods, case mix, statistical analysis, and discussion needed to judge whether BALF-CRP deserves a place in routine respiratory diagnostics or remains a niche adjunct for selected cases. (academic.oup.com)